Biology subjects

Berkowitz, D. E.

Publications and source records attributed to Berkowitz, D. E..

3 recordsLinked to original sources

bioRxiv2026

Cellular uptake of Micro and nano plastics Induces Mitochondrial Dysfunction

Micro and nano plastics (MNPs) have become ubiquitous contaminants in the environment with their occurrence being detected in air, water and food. They can cross biological barriers and slowly build up in different organs, including the placenta, raising concerns about possible impacts on maternal and fetal health. Placenta, a highly metabolically active organ composed primarily of trophoblast cells, requires substantial energy for proper development and function. However, the effects of MNPs exposure on trophoblast biology and mitochondrial health remain poorly understood. This study investigated the in vivo systemic accumulation of MNP in different organs of pregnant mice and their localization within various organelles in vitro. These effects influenced trophoblast energy metabolism and led to reduced migration. Mice received fluorescent polystyrene MNPs via their drinking water. Biodistribution was evaluated in vivo using IVIS whole-body imaging, while ex vivo fluorescence imaging confirmed accumulation of these particles in multiple organs and cells. In parallel, human HTR-8/SVneo trophoblast cells were exposed to MNPs, demonstrating rapid cellular uptake and mitochondrial and nuclear localization via fluorescence microscopy. TEM analysis uncovered mitochondrial structural alterations and the localization of MNPs. Seahorse analysis revealed impaired mitochondrial respiration and oxygen consumption rates, indicating compromised cellular bioenergetics in MNPs-treated cells, which led to inflammation, altered mtDNA copy number, and impaired trophoblast migration. Overall, these findings indicate that pregnant mice exposed to MNPs undergo systemic transfer, with trophoblast uptake marked by mitochondrial dysfunction, inflammation, and reduced migration. Our study identifies mitochondrial dysfunction as a central mechanism underlying MNP-mediated placental toxicity and underscores the potential role of environmental microplastic exposure in adverse pregnancy outcomes. HighlightsO_LICellular uptake of MNPs and their localization across various organelles. C_LIO_LIUptake of MNPs disrupts mitochondrial function and promotes inflammation. C_LIO_LICellular uptake of MNPs impairs cell migration. C_LI

physiology↗

bioRxiv2024

Decreased Extracellular Vesicle Vasorin in Severe Preeclampsia Plasma Mediates Endothelial Dysfunction

BackgroundPreeclampsia (PE) is a serious pregnancy complication affecting 5-8% of pregnancies globally. It is a leading cause of maternal and neonatal morbidity and mortality. Despite its prevalence, the underlying mechanisms of PE remain unclear. This study aimed to determine the potential role of vasorin (VASN) in PE pathogenesis by investigating its levels in extracellular vesicles (EV) and its effects on vascular function. Methods & ResultsWe conducted unbiased proteomics on urine-derived EV from severe PE (sPE) and normotensive pregnant women (NTP), identifying differential protein abundances. Out of one hundred and twenty proteins with [≥] {+/-}1.5-fold regulation at P<0.05 between sPE and NTP, we focused on Vasorin (VASN), which is downregulated in sPE in urinary EV, in plasma EV and in the placenta and is a known regulator of vascular function. We generated EV with high VASN content from both human and murine placenta explants (Plex EV), which recapitulated disease-state-dependent effects on vascular function observed when treating murine aorta rings (MAR) or human aortic endothelial cells (HAEC) with murine or human plasma-derived EV. In normal murine pregnancy, VASN increases with gestational age (GA), and VASN is decreased in plasma EV, in placenta tissue and in Plex EV after intravenous administration of adenovirus encoding short FMS-like tyrosine kinase 1 (sFLT-1), a murine model of PE (murine-PE). VASN is decreased in plasma EV, in placenta tissue and in EV isolated from conditioned media collected from placenta explants (Plex EV) in patients with sPE as compared to NTP. Human sPE and murine-PE plasma EV and Plex EV impair migration, tube formation, and induces apoptosis in human aortic endothelial cells (HAEC) and inhibit acetylcholine-induced vasorelaxation in murine vascular rings (MAR). VASN over-expression counteracts the effects of sPE EV treatment in HAEC and MAR. RNA sequencing revealed that over-expression or knock down of VASN in HAEC results in contrasting effects on transcript levels of hundreds of genes associated with vasculogenesis, endothelial cell proliferation, migration and apoptosis. ConclusionsThe data suggest that VASN, delivered to the endothelium via EV, regulates vascular function and that the loss of EV VASN may be one of the mechanistic drivers of PE. CLINICAL PERSPECTIVEWhat is New O_LIVASN in circulating plasma EV in sPE is reduced compared with VASN content in plasma EV of gestational age-matched pregnant women. C_LIO_LIVASN is encapsulated and transported in EV and plays a pro-angiogenic role during pregnancy. C_LIO_LIVASN should be explored both for its pro-angiogenic mechanistic role and as a novel biomarker and potential predictive diagnostic marker for the onset and severity of PE. C_LI What Are the Clinical Implications? O_LIVASN plays a role in maintaining vascular health and the normal adaptive cardiovascular response in pregnancy. A decrease of VASN is observed in sPE patients contributing to cardiovascular maladaptation. C_LIO_LIStrategies to boost diminished VASN levels and/or to pharmacologically manipulate mechanisms downstream of VASN may be explored for potential therapeutic benefit in PE. C_LIO_LIThe decrease in EV-associated VASN could potentially be used as a (predictive) biomarker for PE. C_LI

molecular biology↗

bioRxiv2023

LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension

BackgroundConduit pulmonary arterial stiffening and the resultant increase in pulmonary vascular impedance has emerged as an important underlying driver of pulmonary arterial hypertension (PAH). Given that matrix deposition is central to vascular remodeling, we evaluated the role of the collagen crosslinking enzyme lysyl oxidase like 2 (LOXL2) in this study. Methods and ResultsHuman pulmonary artery smooth muscle cells (PASMCs) subjected to hypoxia showed increased LOXL2 secretion. LOXL2 activity and expression were markedly higher in primary PASMCs isolated from pulmonary arteries of the rat Sugen 5416 + hypoxia (SuHx) model of severe PH. Similarly, LOXL2 protein and mRNA levels were increased in pulmonary arteries (PA) and lungs of rats with PH (SuHx and monocrotaline (MCT) models). Pulmonary arteries (PAs) isolated from rats with PH exhibited hypercontractility to phenylephrine and attenuated vasorelaxation elicited by acetylcholine, indicating severe endothelial dysfunction. Tensile testing revealed a a significant increase in PA stiffness in PH. Treatment with PAT-1251, a novel small-molecule LOXL2 inhibitor, improved active and passive properties of the PA ex vivo. There was an improvement in right heart function as measured by right ventricular pressure volume loops in-vivo with PAT-1251. Importantly PAT-1251 treatment ameliorated PH, resulting in improved pulmonary artery pressures, right ventricular remodeling, and survival. ConclusionHypoxia induced LOXL2 activation is a causal mechanism in pulmonary artery stiffening in PH, as well as pulmonary artery mechanical and functional decline. LOXL2 inhibition with PAT-1251 is a promising approach to improve pulmonary artery pressures, right ventricular elastance, cardiac relaxation, and survival in PAH. New & NoteworthyPulmonary arterial stiffening contributes to the progression of PAH and the deterioration of right heart function. This study shows that LOXL2 is upregulated in rat models of PH. LOXL2 inhibition halts pulmonary vascular remodeling and improves PA contractility, endothelial function and improves PA pressure, resulting in prolonged survival. Thus, LOXL2 is an important mediator of PA remodeling and stiffening in PH and a promising target to improve PA pressures and survival in PH.

physiology↗